Prostate cancer diagnosed later in US men with HIV
People-centred blood pressure management improves blood pressure in people with HIV
Six-country African PrEP study achieves high levels of persistence and good adherence in young women
Islatravir plus lenacapavir could be the first once-weekly oral HIV treatment
Broadly neutralising antibodies may be partners for long-acting antiretrovirals
HIV diagnoses continue to fall in US states with high PrEP coverage, while others are left behind
Once-weekly antiretrovirals on the horizon
If one antibody won’t work, how about three? Or three in one?
Varying dolutegravir distribution across the body may affect the drug’s ability to suppress the HIV reservoir
